International drug treatment trial

29 April 2014

A paper published in the Drug and Alcohol Dependence Journal last week details development and statistical validity of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT) tool.

A paper published in the Drug and Alcohol Dependence Journal last week details development and statistical validity of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT) tool.

ADAPT is designed to help clinicians tailor individual therapies for treating drug dependence. The study had three aims;

  • Identify reliable indicators and measurement model (i.e. scoring template)
  • Identify patient sub-types
  • Determine if patient sub-type is a predictor of treatment outcomes

Test versions of the ADAPT tool were used at 21 drug treatment services in London (including Blenheim’s service in Southwark, Kappa), Birmingham and Adelaide.

The paper identified three distinct factors addiction severity; coexisting problem complexity; and recovery strength as well as three distinct patient subtypes: Class 1 – moderate level of severity, complexity and strengths; class 2 – low severity, low complexity and high strengths; class 3 – high severity, high complexity and low strengths.

The analysis found that there was some statistically significant validity of sub-type ability to predict outcomes.

There will be a forthcoming discussion paper and the authors write that the ADAPT tool, together with patient history,substance use information and other outcome measures produces a care coordinator dataset that can be used to provide individually tailored treatment plans.

John Jolly, Blenheim CEO says “this is an interesting and exciting study and we are delighted to be included in the pilot sites.”

You can download a copy of the Drug and Alcohol Dependence Journal here.

Posted by